TrialAntimicrobial agents and chemotherapy2026
Virologic insights from the phase 3 REDPINE trial: remdesivir in renally impaired and immunocompromised patients with COVID-19.
Lauren Rodriguez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.